These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34328191)

  • 41. Gut microbiome and liver diseases.
    Tilg H; Cani PD; Mayer EA
    Gut; 2016 Dec; 65(12):2035-2044. PubMed ID: 27802157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
    de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
    Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mushrooms Bioactive as Prebiotics to Modulate Gut Microbiota in Relationships with Causes and Prevention of Liver Diseases (Review).
    Nguepi TIS; Song H
    Int J Med Mushrooms; 2020; 22(6):509-519. PubMed ID: 32865893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut microbiota mediated molecular events and therapy in liver diseases.
    Qi X; Yang M; Stenberg J; Dey R; Fogwe L; Alam MS; Kimchi ET; Staveley-O'Carroll KF; Li G
    World J Gastroenterol; 2020 Dec; 26(48):7603-7618. PubMed ID: 33505139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psoriasis: Interplay between dysbiosis and host immune system.
    Kapoor B; Gulati M; Rani P; Gupta R
    Autoimmun Rev; 2022 Nov; 21(11):103169. PubMed ID: 35964945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Xie C; Halegoua-DeMarzio D
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting Microbiota: What Do We Know about It at Present?
    Derovs A; Laivacuma S; Krumina A
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31405111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
    Zhang X; Coker OO; Chu ES; Fu K; Lau HCH; Wang YX; Chan AWH; Wei H; Yang X; Sung JJY; Yu J
    Gut; 2021 Apr; 70(4):761-774. PubMed ID: 32694178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Gut-liver axis: How intestinal bacteria affect the liver].
    Konturek PC; Harsch IA; Konturek K; Schink M; Zopf Y
    MMW Fortschr Med; 2018 Nov; 160(Suppl 5):11-15. PubMed ID: 30367438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatoprotective effects of Huangqi decoction (Astragali Radix and Glycyrrhizae Radix et Rhizoma) on cholestatic liver injury in mice: Involvement of alleviating intestinal microbiota dysbiosis.
    Zou J; Li W; Wang G; Fang S; Cai J; Wang T; Zhang H; Liu P; Wu J; Ma Y
    J Ethnopharmacol; 2021 Mar; 267():113544. PubMed ID: 33152436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbiota, Liver Diseases, and Alcohol.
    Cassard AM; Gérard P; Perlemuter G
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
    Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies.
    Ebrahimzadeh Leylabadlo H; Ghotaslou R; Samadi Kafil H; Feizabadi MM; Moaddab SY; Farajnia S; Sheykhsaran E; Sanaie S; Shanehbandi D; Bannazadeh Baghi H
    Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):613-627. PubMed ID: 31828683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model.
    Zhao TS; Xie LW; Cai S; Xu JY; Zhou H; Tang LF; Yang C; Fang S; Li M; Tian Y
    Front Cell Infect Microbiol; 2021; 11():717636. PubMed ID: 34760714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
    Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
    Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver.
    Nakajima M; Arimatsu K; Kato T; Matsuda Y; Minagawa T; Takahashi N; Ohno H; Yamazaki K
    PLoS One; 2015; 10(7):e0134234. PubMed ID: 26218067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.
    Nicoletti A; Ponziani FR; Biolato M; Valenza V; Marrone G; Sganga G; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Sep; 25(33):4814-4834. PubMed ID: 31543676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.